More articles from Editorial

Randomised controlled trials and real-life studies: two answers for one question
Sergio Harari

European Respiratory Review Sep 2018, 27 (149) 180080; DOI: 10.1183/16000617.0080-2018
An update on paediatric respiratory diseases
Ralph Epaud

European Respiratory Review Mar 2018, 27 (147) 180013; DOI: 10.1183/16000617.0013-2018
Highlights in acute respiratory failure
Raffaele Scala, Leo Heunks

European Respiratory Review Mar 2018, 27 (147) 180008; DOI: 10.1183/16000617.0008-2018
Pulmonary hypertension: a paradigm for rare pulmonary diseases
Sergio Harari

European Respiratory Review Dec 2017, 26 (146) 170120; DOI: 10.1183/16000617.0120-2017
Rare pulmonary diseases: a common fight
Sergio Harari, Marc Humbert

European Respiratory Review Sep 2017, 26 (145) 170059; DOI: 10.1183/16000617.0059-2017
Bronchoscopy and bleeding risk
Felix J.F. Herth

European Respiratory Review Sep 2017, 26 (145) 170052; DOI: 10.1183/16000617.0052-2017
Out with the old, in with the new for the European Respiratory Review
Sergio Harari

European Respiratory Review Mar 2017, 26 (143) 160118; DOI: 10.1183/16000617.0118-2016
The revolution of pulmonary arterial hypertension
Sergio Harari

European Respiratory Review Dec 2016, 25 (142) 361-363; DOI: 10.1183/16000617.0102-2016
The goal is to go further and do better: but how?
Sergio Harari

European Respiratory Review Mar 2016, 25 (139) 1-3; DOI: 10.1183/16000617.0094-2015
Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
Sergio Harari, Marc Humbert, Francesco Blasi, Harold R. Collard, Marco Matucci-Cerinic, Gerald Simonneau, Carlo Vancheri, Athol U. Wells, Vincent Cottin

European Respiratory Review Sep 2015, 24 (137) 375-377; DOI: 10.1183/16000617.0051-2015

Main menu

User menu

Search

More articles from Editorial

Pages

Contact us